Dermatology · Los Angeles, CA
NPI
1730411091
Since 2010
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5971 Venice Blvd Fl 4, Department of Dermatology
Los Angeles, CA, 90034
Phone (800) 954-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$819
21 services
Medicare patients, 2024
11
Average age 63
Drug cost, 2024
$971K
2,059 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Natalia Vlassova prescribed most often to Medicare patients was Clobetasol Propionate, with 377 prescriptions and refills. In total Natalia Vlassova wrote 2,059 Medicare prescriptions that cost $971K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 377 | 390 | 199 | $9,187 |
| Retin-A Tretinoin | 119 | 128 | 55 | $3,120 |
| Triamcinolone Acetonide Generic | 104 | 118 | 79 | $2,007 |
| Ketoconazole Generic | 102 | 112 | 56 | $1,568 |
| Ciclopirox Generic | 102 | 109 | 47 | $1,911 |
| Tacrolimus Generic | 78 | 94 | 39 | $6,516 |
| Mometasone Furoate Generic | 74 | 78 | 43 | $2,743 |
| Clindamycin Phosphate Generic | 72 | 75 | 38 | $2,194 |
| Fluocinonide Generic | 63 | 67 | 46 | $1,378 |
| Dupixent Pen Dupilumab | 62 | 62 | 11 | $221K |
| Fluorouracil Generic | 60 | 60 | 51 | $2,191 |
| Minoxidil Generic | 56 | 108 | 20 | $632 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 56 | 65 | 25 | $1,628 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 55 | 62 | 25 | $2,337 |
| Econazole Nitrate Generic | 52 | 61 | 30 | $2,033 |
Brand drugs: 364 claims; generic drugs: 1,695 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Natalia Vlassova were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.